BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 30, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 13, 2007
View Archived Issues
Phase I and II studies of belinostat presented at AACR-NCI-EORTC congress
Read More
Weight loss synergy seen with bupropion/naltrexone in obesity study
Read More
Intratumoral TNFerade injection feasible in rectal cancer patients
Read More
Preclinical studies support investigation of AT-101 in lung cancer
Read More
Novel treatment options for bacterial infections claimed in recent patents
Read More
Novel therapeutic agents for genetic disorders reported in recent Technion patent
Read More
Recent patents describe novel antidiabetic agents
Read More
Repligen reports positive phase IIa clinical trial results for RG-2417
Read More
BioGeneriX and Neose report positive data from two phase I trials of GlycoPEG-GCSF
Read More
Teva and Active Biotech initiate enrollment in phase III Allegro clinical trial of laquinimod
Read More
Synta initiates phase I clinical study of novel Hsp90 inhibitor STA-9090
Read More
Dynogen initiates phase IIb of DDP-733 for irritable bowel syndrome with constipation
Read More
Biopure responds to U.K. commission on human medicines' review of Hemopure
Read More
AVEO reports positive results from phase I clinical trial of AV-951
Read More
Novel chronic pain therapy not associated with the development of tolerance
Read More
Selective ERbeta activation using WAY-200070 effective in models of anxiety and depression
Read More
Elan designs gamma-secretase inhibitors with selectivity over Notch
Read More
Results from preclinical, clinical studies support potential of adipiplon as treatment for insomnia
Read More
Peptech renamed Arana Therapeutics and announces new strategic business plan
Read More
Epiphany initiates phase IIb clinical trial of valomaciclovir for the treatment of shingles
Read More
Sanofi pasteur initiates phase II study of cell culture-based seasonal influenza vaccine
Read More
Improved BACE1 inhibitor at Merck & Co.
Read More
AlphaRx reports positive preclinical data from clinical trial of Vansolin
Read More
LifeCycle Pharma reports positive results from clinical trial of LCP-Tacro
Read More
Study shows fewer and smaller dose adjustments necessary in treatment with Transtec
Read More
Cephalon submits supplemental NDA for Fentora for management of breakthrough pain
Read More
FDA grants approval to Abbott for lower-strength tablet formulation of Kaletra tablet
Read More
Novel alpha3 subunit-preferring GABA-A receptor allosteric activator profiled by Neurogen
Read More
